Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023

This bill improves access to mental health care and lowers prescription drug costs for Medicare and Medicaid beneficiaries. Key provisions include expanding incentives for mental health professionals in shortage areas, requiring Medicare Advantage plans to maintain more accurate provider directories, and establishing new rules to prevent excessive cost-sharing for certain medications. The bill also includes measures to ensure pharmacies receive appropriate reimbursement for drugs and to improve telehealth access to behavioral health services. These changes directly affect Medicare and Medicaid beneficiaries, healthcare providers, and pharmacies participating in these programs. Additionally, the bill extends several Medicare and Medicaid provisions that were scheduled to expire.